Skip to main content
Log in

Specific inhibition of an α-galactosyltransferase from Trypanosoma brucei by synthetic substrate analogues

  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

Since the α-D-galactose-(1→3)-D-galactose epitope has been identified to be the major target in the process of hyperacute rejection of xenografts transplanted from nonprimate donors to humans, specific inhibitors of α-galactosyltransferases are of broad interest. Using Trypanosoma brucei, a protozoan parasite causing sleeping sickness and Nagana, we have a very useful model system for the investigation of α-galactosyltransferase inhibitors, since the variant surface glycoprotein (VSG) accounts for about 10% of the total cell protein an this parasite expresses many different galactosyltransferases including the one catalysing the formation of the Galα1→3Gal epitope. In order to study inhibition of galactosylation on the VSG from Trypanosoma brucei, we designed, synthesized and tested substrate analogues of trypanosomal α-galactosyltransferases. Effective inhibitors were a pair of diastereoisomeric UDP-galactose analogs, in which the galactose residue is linked to UDP via a methylene bridge rather than an ester linkage. Hence, galactose cannot be transferred to the respective acceptor substrate VSG or the synthetic acceptor substrate Manα1→6Manα1S-(CH2)7-CH3, which was previously proven to replace VSG effectively [Smith et al. (1996) J Biol Chem 271:6476–82]. Inhibitors have been prepared starting from 1-formyl galactal. The final condensation was performed using UMP morpholidate leading to a pair of diastereomeric compounds in 39% or 30% yield, respectively. These compounds were tested using α-galactosyltransferases prepared from T. brucei membranes and lactose synthetase from bovine milk. While the KM-value for UDP-galactose was determined as 59 µM on bovine lactose synthetase, the KI-values for both inhibitors were 0.3 mM and 1.1 mM respectively, showing that these inhibitors are unable to inhibit enzyme activity significantly. However, using the N-glycan specific α-galactosyltransferase from trypanosomes, the KM-value was determined as 20 µM, while the KI-values were 34 µM and 21 µM respectively. Interestingly, other trypanosomal α-galactosyltransferases, which modify the GPI membrane anchor, are 2 orders of magnitude less effected by the inhibitor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. van Denderen BJ, Salvaris E, Romanella M, Aminian M, Katerelos M, Tange MJ, Pearse MJ, d'Apice AJ (1979) Transplantation 64: 882–88.

    Google Scholar 

  2. Osman N, McKenzie IFC, Ostenried K, Ionnou YA, Desnick RJ, Sandrin MS (1997) Proc Natl Acad Sci (USA) 94: 14677–82.

    Google Scholar 

  3. Ohdan H, Yang YG, Sykes M (1999) Transplant Proc 31: 945–46.

    Google Scholar 

  4. Vanhove B, Charreau B, Cassard A, Pourcel C, Soulillou JP (1998) Transplantation 66: 1477–85.

    Google Scholar 

  5. Pearse MJ, Witort E, Mottram P, Han W, Murray-Segal L, Romanella M, Salvaris E, Shinkel TA, Goodman DJ, d'Apice AJ (1998) Transplantation 66: 748–54.

    Google Scholar 

  6. Bracy JL, Sachs DH, Iacomini J (1998) Science 281: 1845–47.

    Google Scholar 

  7. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie LF (1993) Proc Natl Acad Sci (USA) 90: 11391–95.

    Google Scholar 

  8. Galili U, Shohet SB,Kobrin E, Stults CL, Macher BA(1988) J Biol Chem 263: 17755–62.

    Google Scholar 

  9. Vaughan HA, Loveland BE, Sandrin MS (1994) Transplantation 58: 879–82.

    Google Scholar 

  10. Galili U, Macher BA, Buehler J, Shohet SB (1985) J Exp Med 162: 573–82.

    Google Scholar 

  11. Good AH, Cooper DK, Malcolm AJ, Ippolito RM, Koren E, Neethling FA, Ye Y, Zuhdi N, Lamontagne LR (1992) Transplant Proc 24: 559–62.

    Google Scholar 

  12. Dalmasso AP, Vercellotti GM, Fischel RJ, Bolman RM, Bach FH, Platt JL (1992) Am J Pathol 140: 1157–66.

    Google Scholar 

  13. Ferguson MAJ, Homans SW, Dwek RA, Rademacher TW (1988) Science 239: 753–59.

    Google Scholar 

  14. Pingel S, Duszenko M (1992) Biochem J 283: 479–85.

    Google Scholar 

  15. Pingel S, Field RA, Güther MLS, Duszenko M, Ferguson MAJ (1995) Biochem J 309: 877–82.

    Google Scholar 

  16. Cross, GAM (1996) BioEssays 18: 283–91.

    Google Scholar 

  17. Pingel S, Rheinweiler U, Kolb V, Duszenko M (1998) Biochem J 338: 545–51.

    Google Scholar 

  18. Smith TK, Cottaz S, Brimacombe JS, Ferguson MAJ (1996) J Biol Chem 271: 6476–82.

    Google Scholar 

  19. Ziegler T, Dettmann R, Duszenko M, Kolb V (1996) Carbohydr Res 295: 7–23.

    Google Scholar 

  20. Frische K, Schmidt RR (1994) Liebigs Ann Chem 297–303.

  21. Dettinger H, Kurz G, Lehmann J (1979) Carbohydr Res 74: 301–07.

    Google Scholar 

  22. Meier C, Laux WHG, Bats JW, (1995) Liebigs Ann Chem 1963–1979; and references therein

  23. Dale JA, Mosher HS (1973) J Am Chem Soc 95: 512–19.

    Google Scholar 

  24. Hammerschmidt F, Li YF (1994) Tetrahedron 50: 10253–64; and references therein.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Duszenko.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kolb, V., Amann, F., Schmidt, R.R. et al. Specific inhibition of an α-galactosyltransferase from Trypanosoma brucei by synthetic substrate analogues. Glycoconj J 16, 537–544 (1999). https://doi.org/10.1023/A:1007026122209

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007026122209

Navigation